Current possibilities of using silver proteinate in the treatment of inflammatory diseases of the nose and paranasal sinuses
Open Access
- 4 May 2023
- journal article
- research article
- Published by Remedium, Ltd. in Meditsinskiy sovet = Medical Council
- No. 7,p. 46-51
Abstract
The article evaluates the possibility of using silver proteinate to treat acute inflammatory diseases of the nasal cavity and paranasal sinus mucosa, as well as their complications. Acute rhinitis and rhinosinusitis are among the most common upper respiratory diseases. Viral pathogens are the main agents that trigger the pathological process. At the same time, the bacterial superinfection in some cases may develop due to viral infection, which promotes further development of lingering clinical symptoms up to a complicated course of the disease. The course of rhinosinusitis with underlying COVID-19 infection can be complicated by fungal superinfection and postnasal drip. For these reasons, topical drugs that could be used in the early stages of these conditions should have a number of properties, such as activity against most respiratory viruses and aetiologically significant bacterial pathogens; lack of opportunity to evolute and implement rapid resistance mechanisms in microorganisms; additive effects with other antibacterial drugs; acceleration of regeneration of the nasal cavity and paranasal sinus mucosa with underlying infectious alteration; vasoconstrictive and anti-inflammatory action, without causing an addictive effect, which enables repeated use of the drug in chronic diseases, as well as the absence of local and systemic toxic effects. Sialor (silver proteinate) has all the specified characteristics that were proved in various studies, and consistently demonstrated high clinical efficacy for many years.Keywords
This publication has 23 references indexed in Scilit:
- Silver in medicine: A brief history BC 335 to presentBurns, 2014
- What if Fleming had not discovered penicillin?Saudi Journal of Biological Sciences, 2014
- The prevalence of bacterial infection in acute rhinosinusitis: A Systematic review and meta‐analysisThe Laryngoscope, 2014
- Silver Enhances Antibiotic Activity Against Gram-Negative BacteriaScience Translational Medicine, 2013
- History of the Medical Use of SilverSurgical Infections, 2009
- Antibacterial Activity and Mechanism of Action of the Silver Ion in Staphylococcus aureus and Escherichia coliApplied and Environmental Microbiology, 2008
- Silver in Health Care: Antimicrobial Effects and Safety in Use2006
- A silver coated dressing reduces the incidence of early burn wound cellulitis and associated costs of inpatient treatment: Comparative patient care auditsBurns, 2005
- The common coldThe Lancet, 2003
- Epidemiology, Pathogenesis, and Treatment of the Common ColdAnnals of Allergy, Asthma & Immunology, 1997